# Ceritinib versus chemotherapy in patients with ALK-rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open-label, phase 3 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/ceritinib-versus-chemotherapy-in-patients-with-alk-rearranged-non-small-cell/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Alice T. Shaw,Tae Min Kim,Lucio Crinò,Cesare Gridelli,Katsuyuki Kiura,Geoffrey Liu,Silvia Novello,Alessandra Bearz,Oliver Gautschi,Tony Mok,Makoto Nishio,Giorgio V. Scagliotti,David R. Spigel,Stéphanie Deudon,Cheng Zheng,Serafino Pantano,Patrick Urban,Cristian Massacesi,Kalyanee Viraswami-Appanna,Enriqueta Felip |
| Citations | 582 |
| DOI | 10.1016/s1470-2045(17)30339-x |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://doi.org/10.1016/S1470-2045(17)30339-X. |
| OpenAlex ID | https://openalex.org/W2623725180 |
| PMID | 28602779 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Alice T. Shaw](https://scholariq.org/researchers/alice-t-shaw/)
- [Silvia Novello](https://scholariq.org/researchers/silvia-novello/)
- [David R. Spigel](https://scholariq.org/researchers/david-r-spigel/)
- [Tae Min Kim](https://scholariq.org/researchers/tae-min-kim/)
- [Enriqueta Felip](https://scholariq.org/researchers/enriqueta-felip/)

## Paper journal

- [The Lancet Oncology](https://scholariq.org/journals/the-lancet-oncology/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.